Twist Bioscience (TWST) has seen its share price climb nearly 27% over the past month, sparking some renewed interest among biotech investors. The stock’s movement stands out in a sector that has been ...

Twist Bioscience Corporation and Element Biosciences, Inc. recently announced the launch of the Trinity Freestyle Fast Hybridization workflow for Element's AVITI sequencing platforms, delivering a ...

Fintel reports that on October 7, 2025, Evercore ISI Group maintained coverage of Twist Bioscience (NasdaqGS:TWST) with a ...

In a regulatory filing, Twist Bioscience ( TWST) CEO Emily Leproust disclosed the sale of 31,348 common shares of the company on October 6 a a price of $32.187 per share, or a total consideration of ...

Explore Twist Bioscience (NASDAQ:TWST) developments, Nasdaq Today trends, and impact on Healthcare Stocks and biotech ...

“This collaboration builds on our existing relationship with Element, which has yielded Twist's on-market Element-native kit and 1-hour fast hybridization Trinity solution. Twist will have exclusive ...

Twist Bioscience specializes in synthetic DNA production, providing gene fragments, next generation sequencing (NGS) tools, and antibody discovery platforms to research, diagnostic, pharmaceutical, ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has collaborated with next generation therapeutics company, Synthetic Design Lab (SDL).

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced the appointment of Trynka Shineman Blake to its board of directors. She will also serve as a member of the ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported fiscal third-quarter earnings of $20.4 million. The South San Francisco, ...